Company / Free Cash Flow per Share
NovaBay Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.06
FY2024
5-year range
-$3.32 / -$0.14
FY2020-FY2024
Trend
-178.7%
vs FY2023
Sector context
#102 of 190
Health Care
What the data says
At $-1.06, NovaBay Pharmaceuticals, Inc.'s free cash flow per share ranks #102 of 190 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-9.04 in FY2015 to $-0.14 in FY2020.
Based on SEC 10-K filings.
-1.06 in FY2024.
Improved from $-3.32 to $-1.06 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#102 of 190 in Health CareTop 54% of 190This company -$1.06 Sector average $3.32
▼
-131.9% below sector average
Key checks
Key Insights
- In FY2024, free cash flow per share decreased 178.7% year-over-year.
- Ranks #102 out of 190 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2020.
- Lowest free cash flow per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.06 | -178.7% |
| FY2023 | -$0.38 | +88.5% |
| FY2022 | -$3.32 | -1470.2% |
| FY2021 | -$0.21 | -56.5% |
| FY2020 | -$0.14 | +63.2% |
| FY2019 | -$0.37 | -11.6% |
| FY2018 | -$0.33 | +22.9% |
| FY2017 | -$0.43 | +87.4% |
| FY2016 | -$3.39 | +62.5% |
| FY2015 | -$9.04 | -2568.2% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026